Xue-Zhong Yu

Xue-Zhong Yu

Auto-generated profile, based on publicly available information

Xue-Zhong Yu

Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI, USA; The Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LHLu Han
Lu Han
YWYongxia Wu
Yongxia Wu
KFKun Fang
Kun Fang
Sean Patrick SweeneySean Patrick Sweeney
Sean Patrick Sweeney
URUlyss K. Roesner
Ulyss K. Roesner
GLGustavo Leone
Gustavo Leone
Pancreatic cancer is characterized by abundant desmoplasia, a dense stroma composed of extra-cellular and cellular components, with cancer associated fibroblasts (CAFs) being the major cellular component. However, the tissue(s) of origin for CAFs remains controversial. Here we determine the tissue origin of pancreatic CAFs through comprehensive lineage tracing studies in mice. We find that the splanchnic mesenchyme, the fetal cell layer surrounding the endoderm from which the pancreatic epithelium originates, gives rise to the majority of resident fibroblasts in the normal pancreas. In a genetic mouse model of pancreatic cancer, resident fibroblasts expand and constitute the bulk of CAFs. Single cell RNA profiling identifies gene expression signatures that are shared among the fetal splanchnic mesenchyme, adult fibroblasts and CAFs, suggesting a persistent transcriptional program underlies splanchnic lineage differentiation. Together, this study defines the phylogeny of the mesenchymal component of the pancreas and provides insights into pancreatic morphogenesis and tumorigenesis.

1 January 2018 in Cell Metabolism
Verified
Journal Article
Closed access
SCShilpak Chatterjee
Shilpak Chatterjee
ADAnusara Daenthanasanmak
Anusara Daenthanasanmak
PCParamita Chakraborty
Paramita Chakraborty
MWMegan W. Wyatt
Megan W. Wyatt
PDPayal Dhar
Payal Dhar
Shikhar MehrotraShikhar Mehrotra
Shikhar Mehrotra

3 July 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
SYSha Yan
Sha Yan
ZXZhenyao Xu
Zhenyao Xu
FLFangzhou Lou
Fangzhou Lou
LZLingyun Zhang
Lingyun Zhang
FKFang Ke
Fang Ke
HWHonglin Wang
Honglin Wang
NF-κB is constitutively activated in psoriatic epidermis. However, how activated NF-κB promotes keratinocyte hyperproliferation in psoriasis is largely unknown. Here we report that the NF-κB activation triggered by inflammatory cytokines induces the transcription of microRNA (miRNA) miR-31, one of the most dynamic miRNAs identified in the skin of psoriatic patients and mouse models. The genetic deficiency of miR-31 in keratinocytes inhibits their hyperproliferation, decreases acanthosis and reduces the disease severity in psoriasis mouse models. Furthermore, protein phosphatase 6 (ppp6c), a negative regulator that restricts the G1 to S phase progression, is diminished in human psoriatic epidermis and is directly targeted by miR-31. The inhibition of ppp6c is functionally important for miR-31-mediated biological effects. Moreover, NF-κB activation inhibits ppp6c expression directly through the induction of miR-31, and enhances keratinocyte proliferation. Thus, our data identify NF-κB-induced miR-31 and its target, ppp6c, as critical factors for the hyperproliferation of epidermis in psoriasis.

25 May 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RNRoza Nurieva
Roza Nurieva
STSunil Thomas
Sunil Thomas
TNThang Nguyen
Thang Nguyen
NMNatalia Martin‐Orozco
Natalia Martin‐Orozco
YWYing Wang
Ying Wang
CDChen Dong
Chen Dong
Activated in immune responses, T lymphocytes differentiate into effector cells with potent immune function. CD28 is the most prominent costimulatory receptor for T‐cell activation. However, absence of CD28 costimulation did not completely impair effector function of CD4 or CD8 T cells. Moreover, increasing number of costimulatory molecules are recently found on antigen‐presenting cells to regulate T‐cell activation. To understand the molecular mechanisms that determine T‐cell function or tolerance, we have collectively examined the roles of positive and negative costimulatory molecules. Antigen‐specific naïve CD4 and CD8 T cells, only when activated in the absence of both CD28 and ICOS pathways, were completely impaired in effector function. These tolerant T cells not only were anergic with profound defects in TcR signal transduction but also completely lacked expression of effector‐specific transcription factors. T‐cell tolerance induction in this system requires the action by negative costimulatory molecules; T‐cell proliferation and function was partially restored by inhibiting PD‐1, B7‐H3 or B7S1. This work demonstrates that T‐cell function or tolerance is controlled by costimulatory signals.

17 November 2011 in Blood
Verified
Journal Article
Open access
PDF file
AVAnandharaman Veerapathran
Anandharaman Veerapathran
JPJoseph Pidala
Joseph Pidala
FBFrancisca Beato
Francisca Beato
XYXue-Zhong Yu
Xue-Zhong Yu
CAClaudio Anasetti
Claudio Anasetti
Adoptive transfer of regulatory T cells (Tregs) prevents GVHD in experimental animals. Because antigen activation drives Treg function, we measured the frequency, growth requirements, and function of alloantigen-specific (allospecific) Tregs from human blood. When alloantigen was presented directly, the precursor frequency of allo-specific Tregs in normal individuals was 1.02% (95% confidence interval [95% CI]: 0.65-1.59) and non-Tregs 1.56% (95% CI: 0.94-2.55). When alloantigen was presented indirectly, the frequency of specific Tregs was approximately 100-fold less. Purified Tregs were expanded with APCs, rapamycin, IL-2, and IL-15. In 12 days, allo-specific Tregs expanded 793-fold (95% CI: 480-1107), with duplication approximately every 24 hours. Purified allo-specific Tregs suppressed responses to specific alloantigen selectively and were approximately 100-fold more potent than polyspecific Tregs and nonexpanded Tregs. Allo-specific Tregs maintained high expression of Foxp3, Bcl-2, lymphoid homing receptor CD62L, and chemokine receptor CCR7, predicting sustained function and migration to lymphoid tissues in vivo. Allo-specific Tregs produced TGF-β and IL-10 and expressed more cytoplasmic CTLA-4 compared with non-Tregs. These data provide a platform for the selective expansion of Tregs against major and possibly minor histocompatibility antigens and predict the feasibility of adoptive immunotherapy trials using Tregs with indirect allo-recognition for preventing GVHD while sparing GVL effects.

3 November 2011 in Blood
Verified
Journal Article
Open access
PDF file
YYYu Yu
Yu Yu
DWDapeng Wang
Dapeng Wang
CLChen Liu
Chen Liu
KKKane Kaosaard
Kane Kaosaard
KSKenrick Semple
Kenrick Semple
XYXue-Zhong Yu
Xue-Zhong Yu
Allogeneic hematopoietic cell transplantation (HCT) is effective therapy for hematologic malignancies through T cell–mediated GVL effects. However, HCT benefits are frequently offset by the destructive GVHD, which is also induced by donor T cells. Naive Th can differentiate into Th1 and Th17 subsets and both can mediate GVHD after adoptive transfer into an allogeneic host. Here we tested the hypothesis that blockade of Th1 and Th17 differentiation is required to prevent GVHD in mice. T cells with combined targeted disruption of T-bet and RORγt have defective differentiation toward Th1 and Th17 and skewed differentiation toward Th2 and regulatory phenotypes, and caused ameliorated GVHD in a major MHC-mismatched model of HCT. GVL effects mediated by granzyme-positive CD8 T cells were largely preserved despite T-bet and RORγt deficiency. These data indicate that GVHD can be prevented by targeting Th1 and Th17 transcription factors without offsetting GVL activity.